One frequent characteristic of lung cancer is an aberration in which one or more receptor tyrosine kinases (RTKs), such as MET, EGFR, and ALK, are commonly overexpressed, amplified, or mutated [2]–[4]. This evidence concerns the gene ALK and lung cancer.